STOCK TITAN

Esperion to Participate in Upcoming H.C. Wainwright Global Investment Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Esperion (NASDAQ: ESPR) announced that President and CEO Sheldon Koenig will participate in a fireside chat at the H.C. Wainwright Global Investment Conference on May 24, 2022. The event will feature a presentation and one-on-one meetings, starting at 7:00 am Eastern Standard Time. A live audio webcast will be accessible on the company’s website, with a replay available after the event. Esperion specializes in innovative cholesterol-lowering therapies, focusing on oral, once-daily non-statin medications for patients with high LDL-cholesterol levels.

Positive
  • None.
Negative
  • None.

ANN ARBOR, Mich., May 17, 2022 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR), today announced that President and Chief Executive Officer, Sheldon Koenig, will participate in a fireside chat at the upcoming H.C. Wainwright Global Investment Conference on Tuesday, May 24th, 2022.

Event:H.C. Wainwright Global Investment Conference
Date:Tuesday, May 24th, 2022
Format:Presentation and 1:1 Meetings
Time:7:00 am Eastern Standard Time
Webcast:Link

A live audio webcast can be accessed on the investor and media section of the Esperion website at https://www.esperion.com/investor-relations/events. Access to the webcast replay will be available approximately two hours after completion of the call and will be archived on the Company's website for approximately 90 days.

Esperion Therapeutics

Esperion works hard to make our medicines easy to get, easy to take and easy to have. We discover, develop and commercialize innovative medicines and combinations to lower cholesterol, especially for patients whose needs aren’t being met by the status quo. Our entrepreneurial team of industry leaders is inclusive, passionate and resourceful. We are singularly focused on managing cholesterol so you can improve your health easily. Esperion is the leader in the development of convenient oral, once-daily non-statin LDL-cholesterol lowering drugs for patients with high levels of bad cholesterol. For more information, please visit www.esperion.com and follow us on Twitter at www.twitter.com/EsperionInc.

Contact:
Corporate Communications
corporateteam@esperion.com


FAQ

What is the H.C. Wainwright Global Investment Conference?

The H.C. Wainwright Global Investment Conference is an event where companies present their business strategies and engage with investors.

When is Sheldon Koenig participating in the conference?

Sheldon Koenig will participate on May 24, 2022.

What time does the presentation at the conference start?

The presentation starts at 7:00 am Eastern Standard Time.

How can I listen to the webcast of the event?

The webcast can be accessed through the investor section of Esperion's website.

What does Esperion focus on in terms of medical treatments?

Esperion focuses on developing innovative medicines to lower cholesterol, specifically oral non-statin LDL-cholesterol lowering drugs.

Esperion Therapeutics, Inc.

NASDAQ:ESPR

ESPR Rankings

ESPR Latest News

ESPR Stock Data

476.49M
196.07M
0.5%
66.33%
17.05%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
ANN ARBOR